NIH Funds New Studies on Ethical, Legal and Social Impact of Genomic Information
News May 18, 2016
The awards will fund researchers at interdisciplinary centers through the National Human Genome Research Institute’s (NHGRI) Centers of Excellence in Ethical, Legal and Social Implications Research (CEER) program.
The projects will examine the use of genomic information in the prevention and treatment of infectious diseases; genomic information privacy; communication about prenatal and newborn genomic testing results; and the impact of genomics in American Indian and Alaskan Native communities.
“Many ethical and social problems are not solved by experts in a single discipline alone,” said Joy Boyer, senior program analyst in NHGRI’s Ethical, Legal and Social Implications Research Program. “The CEER program brings together experts from often disparate fields who speak different languages and forms centers where they can study issues across disciplines. These grants are diverse and forward-looking, while also relevant to public health and medicine today.”
The CEER program, established in 2004, is designed to bring together experts in wide-ranging fields — bioethics, law, behavioral and social sciences, epidemiology, public health, public policy, genomics and clinical research — to study the potential societal implications of genomic information and research. CEER projects also help inform public policy and research guidelines, in addition to educating the next generation of researchers.
Each center is built so researchers can look to the future within specific focus areas. “They enable researchers to anticipate new questions and issues that will arise in their particular field of study, and understand how to address them,” said Lawrence Brody, Ph.D., director of the NHGRI Division of Genomics and Society. “The centers examine the human side of research advances, and tackle subjects at the interface of ever-changing technology and medicine.”
The grants, totaling approximately $15 million over four years (pending available funds), will support the following research projects:
Ethical, Legal and Social Issues for Precision Medicine and Infectious Disease
Gail Geller, Sc.D., Jeffrey Kahn, Ph.D., and colleagues at the Johns Hopkins Berman Institute of Bioethics and Johns Hopkins University in Baltimore will use $4,155,172 over four years to examine the ethical implications of using genomic information to help manage the prevention, control and treatment of infectious diseases. The researchers will develop and conduct three pilot projects that study how genomic information affects infectious disease research, public health policy and clinical practice. The work builds on previous NHGRI-supported research.
Genetic Privacy and Identity in Community Settings
Researchers at Vanderbilt University School of Medicine in Nashville, Tennessee, will study privacy risks associated with genomic information. Ellen Wright Clayton, M.D., J.D., and Bradley Malin, Ph.D., will use $4,012,641 over four years to examine factors that influence how people perceive such risks. The researchers will examine the effectiveness of legal and policy efforts to reduce privacy risks, and study the likelihood that lapses in protecting genomic information allow people to be identified. They will develop policies to prevent the loss of privacy that could lead to the use of personal genomic information for unintended purposes, such as to discriminate in decisions about employment and insurance.
Utah Center of Excellence in Ethical, Legal and Social Implications Research
Jeffrey Botkin, M.D., M.P.H., and his colleagues at the University of Utah in Salt Lake City are expanding on research on prenatal testing already supported by NHGRI. A grant for $3,881,732 over four years will enable the researchers to study how family members communicate about prenatal and newborn screening, including how test results and risks are communicated, decision-making and couples communication.
Center on American Indian and Alaska Native Genomic Research
At the University of Oklahoma in Norman, researchers Paul Spicer, Ph.D., Amanda Cobb-Greetham, Ph.D., Cecil Lewis, Ph.D., and their colleagues will examine how the use of genomic information in medical care could potentially impact American Indian and Alaska Native communities and health care systems. A grant for $3,611,308 over four years will allow the university to partner with the Chickasaw and Lakota Sioux tribes and communities and the Southcentral Foundation in Anchorage, Alaska, to study awareness, knowledge and attitudes about genomics in these communities. The collaboration will help create culturally appropriate research and education programs, as well as tools to develop similar programs in other communities.
Gene Editing Technology May Improve Accuracy of Predicting Heart Disease RiskNews
Scientists may now be able to predict whether carrying a specific genetic variant increases a person’s risk for disease using gene editing and stem cell technologies.READ MORE
Genetic Discovery Helps Determine the Difference Between Aggressive & Benign Bone TumorsNews
The first genetic marker for the bone tumor, osteoblastoma, has been discovered. Whole-genome and transcriptome sequencing of human bone tumors revealed that a genetic change that affects the transcription factor, FOS, is a hallmark mutation of osteoblastoma. The results will help clinicians correctly distinguish benign osteoblastoma tumors from aggressive osteosarcoma tumors and direct the correct treatment.READ MORE